🔗 Share this article

An underground economy for unlicensed slimming drugs is propelled by social media fitness personalities and vendors on messaging platforms, according to recent findings.

Investigational Drug Gaining Popularity Online

The experimental drug, which remains in research studies, is being promoted by online personalities for its alleged weight-reducing properties. Followers are encouraged to message these profiles privately for supplier links, while also receiving promotional offers.

Active Trade on Messaging Platforms

Additionally, a robust trade exists on Telegram, where groups with thousands of participants share “before and after” photos, administration instructions and assertions of next-day UK delivery. Vendors market the drug there before directing buyers to WhatsApp for purchases.

Understanding The Experimental Drug

This medication is an investigational injectable created by US drugmaker Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials indicate it could assist individuals lose up to a quarter of their body weight. Referred to as the “triple G”, the drug is being promoted digitally as the successor to Ozempic.

Medical Professionals Voice Concerns

However, doctors and pharmacists have cautions that the sale of what remains an unapproved drug in the United Kingdom is worrisome and could lead to individuals administering products of uncertain source.

Some professionals stated the demand for the experimental drug could be linked to the increasing cost of licensed slimming treatments such as Mounjaro.

Legal Position and Implementation

Selling the unapproved drug on TikTok or messaging apps is illegal in the United Kingdom, as it is an unlicensed drug that cannot be marketed or supplied for personal consumption under the British medical regulations.

Some content creators try to circumvent the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and supply can still violate pharmaceutical, marketing, and consumer regulations, potentially leading to penalties, prosecution or imprisonment.

Service Reaction and Content Removal

Based on TikTok, the service has removed problematic material and banned related keywords and search suggestions. The company stated it was committed to maintaining the platform safe and allocating resources in enhancing compliance measures.

Digital Trading Activities

Research also discovered communities with up to 9,000 members selling the experimental drug using Telegram's integrated discovery tool, which functions like a online catalog. Typing “retatrutide” instantly brings up groups with thousands of members, populated with photos of slimming results, positive testimonials and step-by-step guides for preparing or administering at residence.

Within moments of joining one group, a vendor shared contact information, where the majority of purchases take place. The vendor sent an instruction manual and promised shipping within 48 hours. When questioned whether the product was genuine, one seller said: “You can’t be sure.” Another provided a image of a supposed testing documentation. Not one inquired about weight, medical conditions or previous experience.

Item Details and Costs

Inside these groups, messages display dark colored packages with postal service labels, stating to contain new batches. One message stated: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, prepared at residence with purified liquid, or ready-to-use injectors usually priced at 160 pounds for 20mg. When asked how much time a injector should be used, vendors give contradictory responses ranging from a few weeks to “depends on your body”.

Service Moderation and Security Actions

A spokesperson for the messaging service said it regularly moderated harmful content on its service including content that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“People are injecting substances they can’t verify. Even if the science behind this drug is valid, these online products may not include what they claim,” stated a pharmacy expert, the head of pharmacy at Chemist4U.

A medical professional of Asda Online Doctor connected the surge in interest to recent cost increases for approved slimming drugs such as Mounjaro. “With costs increasing, patients are using online platforms. But counterfeit treatments are highly dangerous. You cannot know what’s contained or whether the conditions they were produced in was sterile,” she explained.

Her staff has already seen patients injured by personal administration from unverified suppliers. “We understand the frustration, but buying from Telegram or WhatsApp is gambling with your well-being,” stated Wyllie. “These substances could be contaminated or improperly measured.”

Manufacturer Statement

A representative from the pharmaceutical company said retatrutide was in third stage clinical trials and had not been reviewed or approved by any government authority globally. “Therefore at this point no one can sell [it] for personal consumption,” they explained, adding that any product “misleadingly claiming itself as a Lilly investigational product not yet authorized … may expose patients to possibly serious health risks”.